Drug recall · August 20, 2014
Carbidopa and Levodopa Tablets USP recall
Why: Failed Tablet/Capsule Specifications: Teva is recalling one lot of Carbidopa and Levodopa Tablets USP, 25mg/100mg due to the potential for superpotent tablets.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Carbidopa and Levodopa Tablets USP, 25mg/100mg, 1000 count bottle, Rx only, Manufactured in Israel by Teva Pharmaceutical IND, LTD., Jeruselem, Israel, for Teva Pharmaceuticals USA, Sellersville, PA, NDC 0093-0293-10
- Lots / codes
lot 29C220, Exp. 11/15
- Quantity
- 3881bottles
- Company
- Teva Pharmaceuticals USA, North Wales, PA
- Distribution
- Nationwide
- Initiated
- June 5, 2014 · Voluntary: Firm initiated
- Classified
- August 13, 2014
- Reported
- August 20, 2014
- Ended
- December 16, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Carbidopa
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.